These 10 Reasons Partnerships is the One Event you Must Attend This Year

We recognize how hard it can be to obtain approval to attend industry conferences right now. Yet we also know how important attending Partnerships in Clinical Trials is to the future of your organization. Partnerships is not just any conference, it is the industry event of the year and it is the one place “Where business gets done.” To make it easier for you this year, we’ve pulled together all the information you’ll need to make the case for your company’s investment.

1. It’s the most respected industry event that brings together the Who’s Who in senior clinical development and outsourcing leadership in an interactive and engaging environment to share strategies and inspire innovation – Get a glimpse into what the future of Pharma R&D will look like and determine how well your company is prepared

2. Over 1800 senior pharma, biotech and CROs executives from over 40 countries attend each year with whom you’ll be able to connect and exchange ideas around sourcing to low cost regions, regulatory, quality and drug safety, M&A and co-development deals and much more

3. The event offers rich content researched with industry leaders and the Partnerships Advisory Board, recognized for providing an unparalleled level of educational sessions and networking opportunities, and has an extensive history of delivering the highest-quality content and out-of-the-box Keynote Speakers not seen at any other event of its kind.

4. Partnerships’ extensive program agenda features over 150 speakers, 50 educational sessions, 8 in-depth workshops, and 8 custom tracks to spark new ideas for transforming our industry with more robust future business models such as risk/reward and virtual drug development.

5. New and innovative interactive learning and networking formats including roundtable sessions, workshops, speed networking, hall tours and a charity run to benefit cancer research.

6. With over 200 of the top clinical trial providers exhibiting at the event, you can spend time reviewing all of the products and services your company is planning on using (such as patient recruitment, central labs, e-technology) on the spot without having to schedule multiple office visits with suppliers.

7. Face-to-face time with your existing partners is critical to the success of our ongoing relationships which you can accomplish through formal pre-set meetings to optimize your time out of the office plus timely discuss ions on maximizing the true value of a strategic partnership with a CRO and understanding the drivers for sourcing for small, medium and large size sponsors

8. With the majority of your competitors attending this event, it is essential that your company is represented and is there to pick up on new industry information, trends and competitive intelligence on strategies in early clinical development, meeting post-marketing research obligations, approaches to RFPs and oversight, process efficiencies and cost containment, site management and more

9. The timely inclusion of topics related to our changing healthcare environment is paramount as we partner to manage uncertainties within our industry with one of the country’s foremost authorities, former Senator Tom Daschle, headlining these discussions

10. High-level discussions and new perspectives around value creation, strategic sourcing and partnerships, investigator sites, alliance

management, cost and contract management, global regulatory requirements and pharmacovigilance, and leading virtual teams among many other hot topics confirms that this conference is the one to attend in 2010

We hope to see you there!